# NOBORI Biolimus-Eluting Versus XIENCE/PROMUS Everolimus-eluting Stent Trial

> **NCT01303640** · PHASE4 · COMPLETED · sponsor: **Takeshi Morimoto** · enrollment: 3235 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Biolimus-eluting stent
- **DEVICE:** Everolimus-eluting stent

## Key facts

- **NCT ID:** NCT01303640
- **Lead sponsor:** Takeshi Morimoto
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 3235 (ACTUAL)
- **Last updated:** 2015-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01303640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01303640, "NOBORI Biolimus-Eluting Versus XIENCE/PROMUS Everolimus-eluting Stent Trial". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01303640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*